Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression

References

• Wang T, Nowrangi D, Yu L, et al. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice. J Neuroinflammation. 2018;15(1):2.
   Web of Science ®Google Scholar
• Gauberti M, Fournier AP, Docagne F, et al. Molecular magnetic resonance imaging of endothelial activation in the central nervous system. Theranostics. 2018;8(5):1195–1212.
   PubMed Web of Science ®Google Scholar
• Li M, Li Z, Ren H, et al. Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2017;37(7):2383–2395.
   PubMed Web of Science ®Google Scholar
• Feng L, Chen Y, Ding R, et al. P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite. J Neuroinflammation. 2015;12(1):190.
   PubMed Web of Science ®Google Scholar
• Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nat Rev Neurosci. 2014;15(2):84–97.
   PubMed Web of Science ®Google Scholar
• Li M, Ren H, Sheth KN, et al. A TSPO ligand attenuates brain injury after intracerebral hemorrhage. FASEB J. 2017;31(8):3278–3287.
   PubMed Web of Science ®Google Scholar
• Gasbarrino K, Zheng H, Hafiane A, et al. Decreased adiponectin-mediated signaling through the AdipoR2 pathway is associated with carotid plaque instability. Stroke. 2017;48(4):915–924.
   PubMed Web of Science ®Google Scholar
• Bloemer J, Pinky PD, Govindarajulu M, et al. Role of adiponectin in central nervous system disorders. Neural Plast. 2018;2018:1.
   Web of Science ®Google Scholar
• Rheinheimer J, de Souza BM, Cardoso NS, et al. Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review. Metab Clin Exp. 2017;74:1–9.
   PubMed Web of Science ®Google Scholar
• Cao G, Jiang N, Hu Y, et al. Ruscogenin attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Int J Mol Sci. 2016;17(9):1418.
   Web of Science ®Google Scholar
• Liu HD, Li W, Chen ZR, et al. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res. 2013;38(10):2072.
   PubMed Web of Science ®Google Scholar
• Zeng J, Chen Y, Ding R, et al. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-kappaB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway. J Neuroinflammation. 2017;14(1):119.
   PubMed Web of Science ®Google Scholar
• Ren H, Kong Y, Liu Z, et al. Selective NLRP3 (pyrin domain–containing protein 3) inflammasome inhibitor reduces brain injury after intracerebral hemorrhage. Stroke. 2018;49(1):184–192.
   PubMed Web of Science ®Google Scholar
• Yang B, Wang S, Yu S, et al. C1q/tumor necrosis factor-related protein 3 inhibits oxidative stress during intracerebral hemorrhage via PKA signaling. Brain Res. 2017;1657:176–184.
   PubMed Web of Science ®Google Scholar
• Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26(4):627.
   PubMed Web of Science ®Google Scholar
• Manaenko A, Lekic T, Ma Q, et al. inhalation ameliorated mast cell mediated brain injury after ICH in mice. Crit Care Med. 2013;41(5):1266–1275.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Jiang M, Fang J, Yang MF, et al. Enhanced therapeutic potential of nano-curcumin against subarachnoid hemorrhage-induced blood-brain barrier disruption through inhibition of inflammatory response and oxidative stress. Mol Neurobiol. 2017;54(1):1–14.
   PubMed Web of Science ®Google Scholar
• Ghadge AA, Khaire AA, Kuvalekar AA. Adiponectin: A potential therapeutic target for metabolic syndrome. Cytokine Growth Factor Rev. 2018;39:151–158.
   PubMed Web of Science ®Google Scholar
• Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci. 2019;20(10):2519.
   PubMed Web of Science ®Google Scholar
• Yanai H, Yoshida H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci. 2019;20(5):1190.
   Web of Science ®Google Scholar
• Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93.
   PubMed Web of Science ®Google Scholar
• Wang W-H, Yu W-H, Dong X-Q, et al. Plasma adiponectin as an independent predictor of early death after acute intracerebral hemorrhage. Clin Chim Acta. 2011;412(17–18):1626–1631.
   PubMed Web of Science ®Google Scholar
• Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–731.
   PubMed Web of Science ®Google Scholar
• Ma Q, Chen S, Hu Q, et al. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann Neurol. 2014;75(2):209–219.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Wei Y, Yang W, et al. Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation. Metab Brain Dis. 2017;32(4):1133–1145.
   PubMed Web of Science ®Google Scholar
• Yuan B, Shen H, Lin L, et al. Recombinant adenovirus encoding NLRP3 RNAi attenuate inflammation and brain injury after intracerebral hemorrhage. J Neuroimmunol. 2015;287:71–75.
   PubMed Web of Science ®Google Scholar
• Yao ST, Cao F, Chen JL, et al. NLRP3 is required for complement-mediated caspase-1 and IL-1beta activation in ICH. J Mol Neurosci. 2017;61(3):385–395.
   PubMed Web of Science ®Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248–255.
   PubMed Web of Science ®Google Scholar